Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors: Carver BS, Serio AM, Bajorin D, Motzer RJ, Stasi J, Bosl GJ, Vickers AJ, Sheinfeld J. Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, NY

Autor: Richie, Jerome P.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2008 26(2):220-220

Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy: Ronnen EA, Kondagunta GV, Bacik J, Marion S, Bajorin DF, Sheinfeld J, Bosl GJ, Motzer RJ, Department of Medicine, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Autor: Richie, Jerome P.

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2006 24(2):170-171

Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, an outcome: McKiernan JM, Motzer RJ, Bajorin DF, Bacik J, Bosl GJ, Sheinfeld J, Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY.

Autor: Rowland, Randall G

Publikováno v: In Urologic Oncology: Seminars and Original Investigations 2004 22(2):158-159

Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node Dissection.

Autor: Baky F; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY., Liso N; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY., Williams B; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, Genitourinary Oncology Service, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, Genitourinary Oncology Service, New York, NY; Department of Medicine, Weill Cornell Medical College, New York, NY., Carver B; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY., Sheinfeld J; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY., Matulewicz RS; Department of Surgery, Memorial Sloan Kettering Cancer Center, Urology Service, New York, NY; Department of Urology, Weill Cornell Medical College, New York, NY. Electronic address: matulewr@mskcc.org.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Dec; Vol. 22 (6), pp. 102217. Date of Electronic Publication: 2024 Sep 03.

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease.

Autor: Gleeson JP; Cancer Research @UCC, College of Medicine and Health, University College Cork, Cork, Ireland.; Medical Oncology Department, Cork University Hospital, Cork, Ireland., Knezevic A; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY., Bromberg M; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY., Patil S; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY., Sheinfeld J; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Carver BS; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Bains M; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Jones DR; Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Bajorin DF; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Bosl GJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., McHugh DJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Funt SA; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Motzer RJ; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY., Feldman DR; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 10; Vol. 42 (26), pp. 3130-3139. Date of Electronic Publication: 2024 Jul 19.